X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

IMUX

Closed

Immunic Inc

0.6904
-0.0071 (-1.02%)
Last Update: 01 Jul 2025 23:15:00
Yesterday: 0.6975
Day's Range: 0.6896 - 0.74
Send
When Written:
 
1.59
Immunic Inc is a clinical-stage biopharmaceutical company that focuses on developing oral therapies for the treatment of chronic inflammatory and autoimmune diseases. The company's lead product candidate, IMU-838, is a selective immune modulator that targets the intracellular metabolism of activated immune cells. It is currently being evaluated in clinical trials for the treatment of multiple sclerosis, ulcerative colitis, and COVID-19. Immunic also has a pipeline of other drug candidates in development for various indications, including inflammatory bowel disease, psoriasis, and lupus. The company was founded in 2016 and is headquartered in New York City.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X